- $111.93m
- $80.21m
- $26.56m
Brief: Coda Octopus Group Appoints Mr. Kevin Kane As Chief Executive Officer Of Coda Octopus Colmek
U.S. RESEARCH ROUNDUP-Eli Lilly, Physicians Realty Trust, Welltower
Coda Octopus rises on quarterly profit
Brief: Coda Octopus Group Q2 Revenue Rose 63.4 Percent To $5.37 Million
Brief: Coda Octopus Group Says Q1 Revenue Fell 24.4 Percent To $5.05 Mln
Brief: Coda Octopus Concludes Gen 2 Diver Augmented Vision Display System Field Trials With NASA AND NAVSEA
Effective Feb 15, 2021, Co Reached New Understanding With Michael Midgley, Co's CFO
Coda Octopus: Falls on disappointing Q3 results as pandemic hits operations
Brief: Coda Octopus Group Reports Fiscal Third Quarter Results
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:25 PM
NASDAQ RESUMED AT 09:48 AM
NASDAQ RESUMED AT 09:41 AM
Brief: Coda Octopus Group Reports Q2 Loss Per Shares Of $0.03
Brief: Coda Octopus Says CEO Voluntarily Decided To Waive Payment Of More Than One Third Of Her Compensation For Next 3 Months
Brief: Coda Octopus Group Posts Q1 Earnings Per Share Of $0.13
Brief: Coda - Granted Exclusive License To Use Its Utility Invention Relating To Face Plate For Commercialization
Brief: Coda Octopus Group Files For Secondary Offering Of Upto 2.3 Mln Shares Of Common Stock - SEC Filing
Brief: Coda Octopus Group On Nov 27 Entered Into An Agreement For A Revolving Line Of Credit - SEC Filing
U.S. STOCKS ON THE MOVE-Alder BioPharma, oil producers, General Motors, gold miners